A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radioresistant tumors: the ETOILE trial

Table 1 Experimental arm (carbon ion therapy)

^aadapted from the experience of NIRS, National Institute of Radiological Sciences (Japan) and HIT, Heidelberg Ion-Beam Therapy Center (Germany)
^bAll treatments are delivered in 16 fractions, 4 fractions per week
CNAO, National Center for Oncological Hadrontherapy; IsoE, Isoeffective dose to ⁶⁰Co or Rx doses delivered with 2 Gy per fraction

ISSN: 1471-2407